• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dow Gains 150 Points; Emerson Electric Earnings Top Views

    5/8/24 2:41:36 PM ET
    $CRCT
    $DV
    $EMR
    $INOD
    Industrial Machinery/Components
    Technology
    Computer Software: Programming Data Processing
    Technology
    Get the next $CRCT alert in real time by email

    U.S. stocks traded mixed toward the end of trading, with the Dow Jones index gaining over 150 points on Wednesday.

    The Dow traded up 0.41% to 39,042.68 while the NASDAQ fell 0.17% to 16,304.23. The S&P 500 also rose, gaining, 0.01% to 5,187.80.

    Check This Out: Top 2 Financial Stocks That May Fall Off A Cliff In May

    Leading and Lagging Sectors

    Utilities shares rose by 0.8% on Wednesday.

    In trading on Wednesday, real estate shares fell by 0.9%.

    Top Headline

    Emerson Electric Co (NYSE:EMR) posted better-than-expected results for its second quarter.

    Emerson Electric reported second-quarter FY24 net sales growth of 17% Y/Y to $4.38 billion, beating the consensus of $4.29 billion. Adjusted EPS improved 25% Y/Y to $1.36, beating the consensus of $1.25.

    For FY24, Emerson Electric revised its net sales growth outlook to 15% – 16% (prior: 14.5% -17%), with underlying sales growth to 5.5%-6.5% (from 4.5%-6.5% earlier) and adjusted EPS to $5.40-$5.50 (from $5.30-$5.45) vs. consensus $5.39.

    Equities Trading UP
                           

    • Reborn Coffee, Inc. (NASDAQ:REBN) shares shot up 95% to $3.3801 after the company announced a significant expansion into the China market through a strategic Master License Agreement with IAID Co.
    • Shares of Cricut, Inc. (NASDAQ:CRCT) got a boost, surging 42% to $7.82 after the company reported better-than-expected first-quarter GAAP EPS results.
    • Innodata Inc. (NASDAQ:INOD) shares were also up, gaining 44% to $9.73 after the company reported a year-over-year increase in first-quarter financial results.

    Equities Trading DOWN

    • Treace Medical Concepts, Inc.. (NASDAQ:TMCI) shares dropped 62% to $4.1850 after the company reported first-quarter financial results and issued FY24 revenue guidance below estimates.
    • Shares of DoubleVerify Holdings, Inc. (NYSE:DV) were down 40% to $18.40 after the company reported first-quarter financial results.
    • Inspire Medical Systems, Inc. (NYSE:INSP) was down, falling 35% to $160.27 following first-quarter results.

    Also Check This Out: How To Earn $500 A Month From Maximus Stock Ahead Of Q2 Earnings

    Commodities

    In commodity news, oil traded up 0.4% to $78.72 while gold traded down 0.1% at $2,322.60.

    Silver traded up 0.3% to $27.62 on Wednesday, while copper fell 1.4% to $4.5435.

    Euro zone

    European shares were higher today. The eurozone's STOXX 600 rose 0.34%, Germany's DAX rose 0.37% and France's CAC 40 gained 0.76%. Spain's IBEX 35 Index rose 0.69%, while London's FTSE 100 rose 0.49%.

    Spain’s industrial output declined by 1.2% year-over-year in March compared to a revised 1.3% gain in the previous month. German industrial production fell by 0.4% month-over-month in March versus a revised 1.7% increase in the earlier month.

    Asia Pacific Markets

    Asian markets closed lower on Wednesday, with Japan's Nikkei falling 1.63%, China's Composite Index declining 0.61%, Hong Kong's Hang Seng Index dipping 0.90% and India's S&P BSE Sensex falling 0.1%.       

    Economics

    • Mortgage applications in the U.S. increased by 2.6% from the prior week in the period ending May 3.
    • U.S. wholesale inventories fell by 0.4% month-over-month in March compared to a revised 0.2% increase in the previous month.
    • The EIA said crude oil inventories in the US declined by 1.361 million barrels in the week ending May 3, compared to a 7.265 million gain in the prior period and versus market estimates of a 1.43 million barrel fall.

    Now Read This: Datadog To Rally Around 25%? Here Are 10 Top Analyst Forecasts For Wednesday

    Get the next $CRCT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CRCT
    $DV
    $EMR
    $INOD

    CompanyDatePrice TargetRatingAnalyst
    Inspire Medical Systems Inc.
    $INSP
    2/13/2026Outperform → Peer Perform
    Wolfe Research
    Inspire Medical Systems Inc.
    $INSP
    2/12/2026$74.00Outperform → Neutral
    Robert W. Baird
    Inspire Medical Systems Inc.
    $INSP
    2/12/2026$70.00Overweight → Equal Weight
    Wells Fargo
    Emerson Electric Company
    $EMR
    2/5/2026$170.00Buy → Hold
    Deutsche Bank
    Inspire Medical Systems Inc.
    $INSP
    1/27/2026$90.00Outperform → Sector Perform
    RBC Capital Mkts
    Emerson Electric Company
    $EMR
    1/27/2026Outperform → Perform
    Oppenheimer
    Inspire Medical Systems Inc.
    $INSP
    1/22/2026$96.00Buy → Hold
    Truist
    Inspire Medical Systems Inc.
    $INSP
    1/22/2026Outperform → Perform
    Oppenheimer
    More analyst ratings

    $CRCT
    $DV
    $EMR
    $INOD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Curet Myriam bought $804 worth of shares (5 units at $160.72) and sold $616 worth of shares (6 units at $102.59), decreasing direct ownership by 0.03% to 3,365 units (SEC Form 4)

    4 - Inspire Medical Systems, Inc. (0001609550) (Issuer)

    11/24/25 8:40:17 PM ET
    $INSP
    Medical/Dental Instruments
    Health Care

    Global Chief Comm. Officer Eddleman Julie bought $12,801 worth of shares (1,096 units at $11.68), converted options into 14,607 shares and covered exercise/tax liability with 4,520 shares, increasing direct ownership by 6% to 209,330 units (SEC Form 4)

    4 - DoubleVerify Holdings, Inc. (0001819928) (Issuer)

    6/17/25 4:24:28 PM ET
    $DV
    Computer Software: Programming Data Processing
    Technology

    Chief Executive Officer Zagorski Mark bought $13,327 worth of shares (1,141 units at $11.68), converted options into 32,249 shares and covered exercise/tax liability with 17,836 shares, increasing direct ownership by 4% to 453,639 units (SEC Form 4)

    4 - DoubleVerify Holdings, Inc. (0001819928) (Issuer)

    6/17/25 4:22:54 PM ET
    $DV
    Computer Software: Programming Data Processing
    Technology

    $CRCT
    $DV
    $EMR
    $INOD
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Treace Medical Concepts Inc.

    SCHEDULE 13G/A - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Subject)

    2/12/26 5:57:53 PM ET
    $TMCI
    Medical/Dental Instruments
    Health Care

    Inspire Medical Systems Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Inspire Medical Systems, Inc. (0001609550) (Filer)

    2/11/26 4:32:10 PM ET
    $INSP
    Medical/Dental Instruments
    Health Care

    SEC Form SCHEDULE 13G filed by Inspire Medical Systems Inc.

    SCHEDULE 13G - Inspire Medical Systems, Inc. (0001609550) (Subject)

    2/10/26 11:17:43 AM ET
    $INSP
    Medical/Dental Instruments
    Health Care

    $CRCT
    $DV
    $EMR
    $INOD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Levatich Matthew S sold $239,349 worth of shares (1,476 units at $162.16), decreasing direct ownership by 6% to 24,349 units (SEC Form 4)

    4 - EMERSON ELECTRIC CO (0000032604) (Issuer)

    2/12/26 4:08:44 PM ET
    $EMR
    Consumer Electronics/Appliances
    Technology

    Chief Innovation Officer Scanlan Sean F. exercised 16,875 shares at a strike of $1.05, increasing direct ownership by 2% to 706,474 units (SEC Form 4)

    4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)

    2/11/26 9:00:03 PM ET
    $TMCI
    Medical/Dental Instruments
    Health Care

    Officer Weatherby Carlton covered exercise/tax liability with 327 shares, decreasing direct ownership by 4% to 7,130 units (SEC Form 4)

    4 - Inspire Medical Systems, Inc. (0001609550) (Issuer)

    2/11/26 5:23:36 PM ET
    $INSP
    Medical/Dental Instruments
    Health Care

    $CRCT
    $DV
    $EMR
    $INOD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Treace Updates Date of Fourth Quarter and Full-Year 2025 Financial Results Release to February 27, 2026

    PONTE VEDRA, Fla., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ:TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced that it will release financial results for the fourth quarter and full year of 2025 before the open of trading on Friday, February 27, 2026. Company management will host a conference call to discuss financial results beginning at 8:00 am ET. Investors interested in listening to the conference call may do so by registering. Once registered, participants will receive dial-in numbers and a unique pin to join the call and ask qu

    2/12/26 5:13:32 PM ET
    $TMCI
    Medical/Dental Instruments
    Health Care

    Reborn Coffee Provides Operational Update on Reborn Logistics, Highlighting Operating Income Progress and 2026 Growth Outlook

    Reborn Logistics Subsidiary Reports Preliminary Unaudited Q4 2025 Revenue of $2.5 Million and Operating Income of $0.6 Million  Company Targets $15 Million in Reborn Logistics Revenue in 2026 BREA, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Reborn Coffee Inc. (NASDAQ:REBN) (the "Company"), a leader in the specialty coffee market, today provided a business update on Reborn Logistics, its wholly owned logistics subsidiary established to strengthen supply chain infrastructure and support the Company's expanding domestic and international operations. Following the Company's September 16, 2025, announcement establishing Reborn Logistics, the Company believes the subsidiary will continue to bui

    2/12/26 8:30:00 AM ET
    $REBN
    Restaurants
    Consumer Discretionary

    Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results

    Fourth quarter revenue growth of 12% and full year revenue growth of 14%Fourth quarter net income per diluted share of $4.66; adjusted net income per diluted share of $1.65Full year net income per diluted share of $4.89; adjusted net income per diluted share of $2.42Operating cash flow of $52.5 million in the fourth quarter with full year operating cash flow of $117.0 million MINNEAPOLIS, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE:INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for the quarter and

    2/11/26 4:02:00 PM ET
    $INSP
    Medical/Dental Instruments
    Health Care

    $CRCT
    $DV
    $EMR
    $INOD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $CRCT
    $DV
    $EMR
    $INOD
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    Inspire Medical Systems downgraded by Wolfe Research

    Wolfe Research downgraded Inspire Medical Systems from Outperform to Peer Perform

    2/13/26 8:29:00 AM ET
    $INSP
    Medical/Dental Instruments
    Health Care

    Inspire Medical Systems downgraded by Robert W. Baird with a new price target

    Robert W. Baird downgraded Inspire Medical Systems from Outperform to Neutral and set a new price target of $74.00

    2/12/26 7:22:54 AM ET
    $INSP
    Medical/Dental Instruments
    Health Care

    Inspire Medical Systems downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded Inspire Medical Systems from Overweight to Equal Weight and set a new price target of $70.00

    2/12/26 7:22:44 AM ET
    $INSP
    Medical/Dental Instruments
    Health Care

    March 21, 2023 - FDA Roundup: March 21, 2023

    For Immediate Release: March 21, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA completed its second pre-market consultation for a human food made from cultured animal cells. The firm will use animal cell culture technology to take living cells from chickens and grow the cells in a controlled environment to make the cultured

    3/21/23 3:12:46 PM ET
    $INSP
    Medical/Dental Instruments
    Health Care

    $CRCT
    $DV
    $EMR
    $INOD
    Leadership Updates

    Live Leadership Updates

    View All

    Inspire Medical Systems, Inc. Announces Preliminary Unaudited Revenue Results for the Fourth Quarter and Full Year 2025 and Provides Initial 2026 Revenue Guidance

    MINNEAPOLIS, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE:INSP) ("Inspire", or the "Company"), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today announced certain preliminary, unaudited results for the fourth quarter and full year ended December 31, 2025, and provided its initial full year 2026 revenue guidance. Further, the Company announced the appointment of Matt Osberg as Executive Vice President and Chief Financial Officer. Preliminary, Unaudited Fourth Quarter and Full Year 2025 Revenue Revenue for the fourth quarter of 2025 is anticipate

    1/12/26 6:45:00 AM ET
    $INSP
    Medical/Dental Instruments
    Health Care

    DoubleVerify Appoints Stuart Flint to Lead EMEA Operations

    Former TikTok and Yahoo executive brings decades of commercial leadership experience to accelerate DV's global growth DoubleVerify ("DV") (NYSE:DV), a leading software platform to verify media quality, optimize ad performance, and prove campaign outcomes, today announced the appointment of Stuart Flint as Managing Director, EMEA. In this role, Flint will oversee DV's operations across the region and help advance the company's go-to-market strategy, expand client relationships, and accelerate growth throughout EMEA. "As global advertisers demand greater transparency and performance across their campaigns, we continue to expand to meet their needs," said Steve Mougis, Global Chief Commercia

    12/4/25 9:00:00 AM ET
    $DV
    Computer Software: Programming Data Processing
    Technology

    Reborn Coffee Announces the Formation of an Advisory Board and Appointment of Hisham Elkoustaf as Chair

    New Advisory Board to Drive Innovation and Growth Globally BREA, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Reborn Coffee Inc. (NASDAQ:REBN), a leader in the specialty coffee market, today announced the formation of its new advisory board to drive innovation and growth within the company and appointed Hisham Elkoustaf as its chair. The advisory boards will consist of a diverse group of professionals who will help to shape the strategic direction of Reborn Coffee and ensure that its remain committed to its values of sustainability and quality. Mr. Elkoustaf is an esteemed attorney with over 20 years of experience at the intersection of corporate law, economic development, and foreign poli

    10/23/25 9:00:01 AM ET
    $REBN
    Restaurants
    Consumer Discretionary

    $CRCT
    $DV
    $EMR
    $INOD
    Financials

    Live finance-specific insights

    View All

    Treace Updates Date of Fourth Quarter and Full-Year 2025 Financial Results Release to February 27, 2026

    PONTE VEDRA, Fla., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ:TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced that it will release financial results for the fourth quarter and full year of 2025 before the open of trading on Friday, February 27, 2026. Company management will host a conference call to discuss financial results beginning at 8:00 am ET. Investors interested in listening to the conference call may do so by registering. Once registered, participants will receive dial-in numbers and a unique pin to join the call and ask qu

    2/12/26 5:13:32 PM ET
    $TMCI
    Medical/Dental Instruments
    Health Care

    Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results

    Fourth quarter revenue growth of 12% and full year revenue growth of 14%Fourth quarter net income per diluted share of $4.66; adjusted net income per diluted share of $1.65Full year net income per diluted share of $4.89; adjusted net income per diluted share of $2.42Operating cash flow of $52.5 million in the fourth quarter with full year operating cash flow of $117.0 million MINNEAPOLIS, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE:INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for the quarter and

    2/11/26 4:02:00 PM ET
    $INSP
    Medical/Dental Instruments
    Health Care

    Cricut to Announce Fourth Quarter 2025 Financial Results on March 3, 2026

    SOUTH JORDAN, Utah, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Cricut, Inc. ("Cricut") (NASDAQ:CRCT), the creative technology company that has brought a connected platform for making to millions of users worldwide, today announced it will report its financial results for the fourth quarter ended December 31, 2025 after the U.S. markets close on Tuesday, March 3, 2026. Cricut management will host a conference call and webcast to discuss the results that afternoon at 3:00 p.m. Mountain Time (5:00 p.m. Eastern Time). A live webcast of the earnings call will be available on Cricut's investor relations website at https://investor.cricut.com/. A webcast replay will be available after the live event. To

    2/10/26 4:05:00 PM ET
    $CRCT
    Industrial Machinery/Components
    Technology

    $CRCT
    $DV
    $EMR
    $INOD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Innodata Inc.

    SC 13D/A - INNODATA INC (0000903651) (Subject)

    11/26/24 5:19:30 PM ET
    $INOD
    EDP Services
    Technology

    SEC Form SC 13G filed by Treace Medical Concepts Inc.

    SC 13G - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Subject)

    11/14/24 3:38:23 PM ET
    $TMCI
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Treace Medical Concepts Inc.

    SC 13G/A - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Subject)

    11/12/24 6:01:03 PM ET
    $TMCI
    Medical/Dental Instruments
    Health Care